How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals. [electronic resource]

By: Contributor(s): Producer: 20120918Description: 679-88 p. digitalISSN:
  • 1473-5628
Subject(s): Online resources: In: Nuclear medicine communications vol. 33
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.